| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.049 | 0.4 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.4 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |